Ge, Y., Domschke, C., Schott, S., Heil, J., Rom, J., Blumenstein, M., . . . Schütz, F. (2012). Metronomic cyclophosphamide treatment in metastasized breast cancer patients: Immunological effects and clinical outcome. Cancer immunology immunotherapy, 61(3), . https://doi.org/10.1007/s00262-011-1106-3
Chicago-Zitierstil (17. Ausg.)Ge, Yingzi, et al. "Metronomic Cyclophosphamide Treatment in Metastasized Breast Cancer Patients: Immunological Effects and Clinical Outcome." Cancer Immunology Immunotherapy 61, no. 3 (2012). https://doi.org/10.1007/s00262-011-1106-3.
MLA-Zitierstil (9. Ausg.)Ge, Yingzi, et al. "Metronomic Cyclophosphamide Treatment in Metastasized Breast Cancer Patients: Immunological Effects and Clinical Outcome." Cancer Immunology Immunotherapy, vol. 61, no. 3, 2012, https://doi.org/10.1007/s00262-011-1106-3.